Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabine Semrau

Showing results (1-10 of 128) with videos related to

Pageof 13
Sort By:
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 22, 2019
[In HPV-associated oropharyngeal cancer, chemoradiotherapy with cisplatin is superior to bioradiotherapy with cetuximab in terms of overall survival]Sabine Semrau
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|July 19, 2021
[Prediction of pathologic complete response in esophageal cancer after neoadjuvant radiochemotherapy using FDG-PET/CT and diffusion-weighted MRI]Markus Hecht, Sabine Semrau
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 9, 2019
[FOLFIRINOX after resection of pancreatic cancer sets new standards-systemic therapy providing an impulse for local treatment in resectable pancreatic cancer]Sabine Semrau, Dorota Lubgan
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 28, 2024
[Through the labyrinth towards the goal: doxorubicin/trabectedin in metastatic and initially unresectable leiomyosarcoma]Felix Grabenbauer, Sabine Semrau
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 11, 2022
[Is elective irradiation of lymph node levels IV and Vb necessary in nasopharyngeal carcinoma?]Sabine Semrau, Marlen Haderlein
Frontiers of Radiation Therapy and Oncology|December 4, 2009
Stage III: definitive chemoradiotherapyRainer Fietkau, Sabine Semrau
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 18, 2020
[Aggressive dose de-escalation in adjuvant therapy for HPV-associated oropharyngeal cancer. Is half of everything enough?]Markus Hecht, Sabine Semrau
Histopathology|August 15, 2015
Intra-abdominal ALK-positive anaplastic large cell lymphoma in a patient with neurofibromatosis type 1Abbas Agaimy, Sabine Semrau, Marco Heinz
International Journal of Radiation Oncology, Biology, Physics|March 31, 2010
Baseline cardiopulmonary function as an independent prognostic factor for survival of inoperable non-small-cell lung cancer after concurrent chemoradiotherapy: a single-center analysis of 161 casesSabine Semrau, Gunther Klautke, Rainer Fietkau
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 3, 2006
Concurrent radiotherapy and taxane chemotherapy in patients with locoregional recurrence of breast cancer. A retrospective analysisSabine Semrau, Bernd Gerber, Toralf Reimer, et al.
Pageof 13

Showing results (1-10 of 128) with videos related to

Sort By:
Pageof 13
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 22, 2019
[In HPV-associated oropharyngeal cancer, chemoradiotherapy with cisplatin is superior to bioradiotherapy with cetuximab in terms of overall survival]Sabine Semrau
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|July 19, 2021
[Prediction of pathologic complete response in esophageal cancer after neoadjuvant radiochemotherapy using FDG-PET/CT and diffusion-weighted MRI]Markus Hecht, Sabine Semrau
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 9, 2019
[FOLFIRINOX after resection of pancreatic cancer sets new standards-systemic therapy providing an impulse for local treatment in resectable pancreatic cancer]Sabine Semrau, Dorota Lubgan
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 28, 2024
[Through the labyrinth towards the goal: doxorubicin/trabectedin in metastatic and initially unresectable leiomyosarcoma]Felix Grabenbauer, Sabine Semrau
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 11, 2022
[Is elective irradiation of lymph node levels IV and Vb necessary in nasopharyngeal carcinoma?]Sabine Semrau, Marlen Haderlein
Frontiers of Radiation Therapy and Oncology|December 4, 2009
Stage III: definitive chemoradiotherapyRainer Fietkau, Sabine Semrau
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 18, 2020
[Aggressive dose de-escalation in adjuvant therapy for HPV-associated oropharyngeal cancer. Is half of everything enough?]Markus Hecht, Sabine Semrau
Histopathology|August 15, 2015
Intra-abdominal ALK-positive anaplastic large cell lymphoma in a patient with neurofibromatosis type 1Abbas Agaimy, Sabine Semrau, Marco Heinz
International Journal of Radiation Oncology, Biology, Physics|March 31, 2010
Baseline cardiopulmonary function as an independent prognostic factor for survival of inoperable non-small-cell lung cancer after concurrent chemoradiotherapy: a single-center analysis of 161 casesSabine Semrau, Gunther Klautke, Rainer Fietkau
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 3, 2006
Concurrent radiotherapy and taxane chemotherapy in patients with locoregional recurrence of breast cancer. A retrospective analysisSabine Semrau, Bernd Gerber, Toralf Reimer, et al.
Pageof 13